Mrudula Donepudi

Mrudula Donepudi

Company: Editas Medicine

Job title: Director, Scientific Communications and Clinical Science


Mrudula Donepudi is a clinical development and medical affairs professional with over 12 years of biotech and pharmaceutical industry experience in the Boston/Cambridge biotech hub. During her career, she’s been part of teams that have brought drugs successfully through regulatory approval and launch in the market in oncology and liver disease. Her experience spans clinical research and operations, and she has led medical writing and scientific communications teams. Mrudula joined Editas Medicine, Inc. in January 2018 and is currently Director of Clinical Science and Scientific Communications. She completed a post-doctoral fellowship at Memorial Sloan Kettering Cancer Center in New York City, and was awarded a s a PhD in Biochemistry from the University of Zurich, Switzerland.


Panel Discussion – Discussing Challenges of Gene Editing Approaches in the Gene Therapy Space 2:00 pm

Translating from pre-clinical studies into the clinic How to decide which gene editing approach is best for each indication Navigating the regulatory landscape Ensuring patients understand what treatment involves compared to current options Possible applications of gene editing technology across blood disease indicationsRead more

day: Day Two

Designing a Clinical Trial for a Gene-Edited Gene Therapy Treatment 1:30 pm

Translating CRISPR-Cas9 technology into the clinic: key considerations Addressing potential quality and compliance challenges specific to gene editing trialsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.